Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.89 - $15.04 $150,053 - $162,477
10,803 Added 70.24%
26,184 $363,000
Q4 2023

Feb 14, 2024

BUY
$13.36 - $15.43 $205,490 - $237,328
15,381 New
15,381 $219,000
Q1 2023

May 15, 2023

SELL
$15.28 - $16.48 $69,417 - $74,868
-4,543 Reduced 29.8%
10,703 $176,000
Q4 2022

Feb 14, 2023

BUY
$12.42 - $15.62 $20,132 - $25,320
1,621 Added 11.9%
15,246 $237,000
Q3 2022

Nov 14, 2022

SELL
$12.8 - $28.65 $204,211 - $457,082
-15,954 Reduced 53.94%
13,625 $177,000
Q2 2022

Aug 15, 2022

BUY
$13.12 - $15.03 $185,215 - $212,178
14,117 Added 91.3%
29,579 $415,000
Q1 2022

May 16, 2022

SELL
$13.54 - $15.35 $127,587 - $144,643
-9,423 Reduced 37.87%
15,462 $221,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $327,735 - $408,113
24,885 New
24,885 $339,000
Q2 2021

Aug 16, 2021

SELL
$16.55 - $18.64 $225,080 - $253,504
-13,600 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$16.71 - $19.9 $227,256 - $270,640
13,600 New
13,600 $248,000
Q3 2020

Nov 16, 2020

SELL
$17.1 - $19.19 $220,572 - $247,531
-12,899 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$14.59 - $19.5 $188,196 - $251,530
12,899 New
12,899 $231,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.